Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Signos vs The Virtual NP

Signos
Graded #293

Higher grade

vs+0.6000000000000014
The Virtual NP
Graded #314

Lower grade

The verdict

Signos takes it — 61.4/100 to 60.8/100, but only just.

Signos grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Signos (Signos+) is a metabolic-health platform that bundles clinician-prescribed compounded GLP-1 (semaglutide) with an FDA-cleared continuous glucose monitor (CGM) and app — pairing the medication with… The Virtual NP is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueThe Virtual NP +1
44
45
Dose & formulationSignos +11
64
53
Clinical oversightThe Virtual NP +10
84
94
Labs & monitoringSignos +17
71
54
FulfillmentSignos +7
71
64
Contract termsThe Virtual NP +35
20
55
Signos · left barThe Virtual NP · right bar

The numbers

MetricSignosThe Virtual NP
WeighScore61.4/10060.8/100
GradeCC
Scorecard rank#293#314
Semaglutide$199/mo (6-month plan, compounded)Not disclosed
Tirzepatide$199/mo (starting dose, compounded)Not disclosed
CoverageCoverage not published7 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Signos

Graded #293 · C

Strengths

  • Bundles compounded GLP-1 (semaglutide) with an FDA-cleared CGM and app — glucose-guided weight loss, not just medication
  • Starting at $199/mo on a 6-month program, with the CGM included at no extra cost
  • Free rapid shipping; HSA/FSA eligible
  • Real-time glucose insights and app coaching to help sustain results after GLP-1

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products
  • Headline price is a 6-month-program rate, not month-to-month
  • Only semaglutide is shown in the program; tirzepatide availability is not confirmed
  • Compounding pharmacy partner and state availability are not published on the landing page
The Virtual NP

Graded #314 · C

Strengths

  • FDA-approved branded Zepbound and Wegovy only, no compounded
  • Transparent fees: 99 visit or 75 per month membership
  • HSA/FSA accepted and prior authorization assistance offered
  • NP-led with same or next-day booking and home shipping

Where it loses points

  • Branded only, so medication cost is high and billed separately
  • Limited to seven states
  • No compounded lower-cost GLP-1 alternative
  • Single-provider practice may limit scale and hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard